Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
We report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 8...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2016/8324791 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552718312407040 |
---|---|
author | Javier De Luca-Johnson Jose I. Ruades Ninfea Lauren Pearson Joanna Conant Ronald Bryant Neil A. Zakai Mary E. Tang |
author_facet | Javier De Luca-Johnson Jose I. Ruades Ninfea Lauren Pearson Joanna Conant Ronald Bryant Neil A. Zakai Mary E. Tang |
author_sort | Javier De Luca-Johnson |
collection | DOAJ |
description | We report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 84% were eosinophil lineage. Cytogenetic analysis revealed a t(5;12)(q31~33;p13). FISH was negative for PDGFRB rearrangement but additional FISH testing demonstrated an ACSL6 rearrangement. ETV6-ACSL6 gene fusion is a rare abnormality that most often presents as a myeloproliferative-type disorder with prominent eosinophilia or basophilia. Review of the literature yielded a total of 11 previous cases. This gene fusion results in a t(5;12)(q31~33;p13) that mimics the t(5;12) found in ETV6-PDGFRB neoplasms. Identification of the fusion genes involved in t(5;12) in eosinophilia-associated myeloproliferative disorders is crucial to direct an effective treatment plan. In particular, while tyrosine kinase inhibitor therapy is effective in patients with PDGFRB rearrangement, there is little information on imatinib efficacy in patients with ETV6-ACSL6 gene fusion. Our patient was found to be nonresponsive to imatinib therapy. |
format | Article |
id | doaj-art-7861242358aa47eb844ded7747371d4e |
institution | Kabale University |
issn | 1687-9627 1687-9635 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Medicine |
spelling | doaj-art-7861242358aa47eb844ded7747371d4e2025-02-03T05:58:05ZengWileyCase Reports in Medicine1687-96271687-96352016-01-01201610.1155/2016/83247918324791Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the LiteratureJavier De Luca-Johnson0Jose I. Ruades Ninfea1Lauren Pearson2Joanna Conant3Ronald Bryant4Neil A. Zakai5Mary E. Tang6Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Medicine, Division of Hematology and Oncology, University of Vermont Medical Center, 89 Beaumont Avenue, Given E-214-UVM363, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USAWe report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 84% were eosinophil lineage. Cytogenetic analysis revealed a t(5;12)(q31~33;p13). FISH was negative for PDGFRB rearrangement but additional FISH testing demonstrated an ACSL6 rearrangement. ETV6-ACSL6 gene fusion is a rare abnormality that most often presents as a myeloproliferative-type disorder with prominent eosinophilia or basophilia. Review of the literature yielded a total of 11 previous cases. This gene fusion results in a t(5;12)(q31~33;p13) that mimics the t(5;12) found in ETV6-PDGFRB neoplasms. Identification of the fusion genes involved in t(5;12) in eosinophilia-associated myeloproliferative disorders is crucial to direct an effective treatment plan. In particular, while tyrosine kinase inhibitor therapy is effective in patients with PDGFRB rearrangement, there is little information on imatinib efficacy in patients with ETV6-ACSL6 gene fusion. Our patient was found to be nonresponsive to imatinib therapy.http://dx.doi.org/10.1155/2016/8324791 |
spellingShingle | Javier De Luca-Johnson Jose I. Ruades Ninfea Lauren Pearson Joanna Conant Ronald Bryant Neil A. Zakai Mary E. Tang Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature Case Reports in Medicine |
title | Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature |
title_full | Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature |
title_fullStr | Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature |
title_full_unstemmed | Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature |
title_short | Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature |
title_sort | myeloid neoplasms with t 5 12 and etv6 acsl6 gene fusion potential mimickers of myeloid neoplasm with pdgfrb rearrangement case report with imatinib therapy and review of the literature |
url | http://dx.doi.org/10.1155/2016/8324791 |
work_keys_str_mv | AT javierdelucajohnson myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature AT joseiruadesninfea myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature AT laurenpearson myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature AT joannaconant myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature AT ronaldbryant myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature AT neilazakai myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature AT maryetang myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature |